H. Manning
Faculty Member
Last active: 3/22/2018

  1. Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Garrett JT, Olivares MG, Rinehart C, Granja-Ingram ND, Sánchez V, Chakrabarty A, Dave B, Cook RS, Pao W, McKinely E, Manning HC, Chang J, Arteaga CL (2011) Proc Natl Acad Sci U S A 108(12): 5021-6
    › Primary publication · 21385943 (PubMed) · PMC3064360 (PubMed Central)
  2. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC (2011) J Nucl Med 52(1): 107-14
    › Primary publication · 21149488 (PubMed) · PMC3027353 (PubMed Central)
  3. Multispectral fluorescence imaging to assess pH in biological specimens. Hight MR, Nolting DD, McKinley ET, Lander AD, Wyatt SK, Gonyea M, Zhao P, Manning HC (2011) J Biomed Opt 16(1): 016007
    › Primary publication · 21280913 (PubMed) · PMC3041815 (PubMed Central)
  4. Molecular imaging metrics to evaluate response to preclinical therapeutic regimens. Smith RA, Guleryuz S, Manning HC (2011) Front Biosci (Landmark Ed) : 393-410
    › Primary publication · 21196177 (PubMed) · PMC3023459 (PubMed Central)
  5. Magnetic resonance in the era of molecular imaging of cancer. Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE (2011) Magn Reson Imaging 29(5): 587-600
    › Primary publication · 21524870 (PubMed) · PMC3285504 (PubMed Central)
  6. ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Miller TW, Balko JM, Fox EM, Ghazoui Z, Dunbier A, Anderson H, Dowsett M, Jiang A, Smith RA, Maira SM, Manning HC, González-Angulo AM, Mills GB, Higham C, Chanthaphaychith S, Kuba MG, Miller WR, Shyr Y, Arteaga CL (2011) Cancer Discov 1(4): 338-51
    › Primary publication · 22049316 (PubMed) · PMC3204388 (PubMed Central)
  7. A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine. Guo N, Xie J, Manning HC, Deane NG, Ansari MS, Coffey RJ, Gore J, Price RR, Baldwin RM, McIntyre JO (2011) Mol Imaging Biol 13(2): 257-64
    › Primary publication · 20532643 (PubMed) · PMC4180216 (PubMed Central)
  8. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL (2011) Cancer Res 71(21): 6773-84
    › Primary publication · 21908557 (PubMed) · PMC3206206 (PubMed Central)
  9. 18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer. McKinley ET, Bugaj JE, Zhao P, Guleryuz S, Mantis C, Gokhale PC, Wild R, Manning HC (2011) Clin Cancer Res 17(10): 3332-40
    › Primary publication · 21257723 (PubMed) · PMC3122480 (PubMed Central)
  10. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. Ayers GD, McKinley ET, Zhao P, Fritz JM, Metry RE, Deal BC, Adlerz KM, Coffey RJ, Manning HC (2010) J Ultrasound Med 29(6): 891-901
    › Primary publication · 20498463 (PubMed) · PMC2925269 (PubMed Central)